Seroprevalence and demographic determinants of human T-lymphotropic virus type 1 and 2 infections among first-time blood donors--United States, 2000-2009.
about
Seroprevalence of HTLV-1 and HTLV-2 amongst mothers and children in Malawi within the context of a systematic review and meta-analysis of HTLV seroprevalence in AfricaOrigin and prevalence of human T-lymphotropic virus type 1 (HTLV-1) and type 2 (HTLV-2) among indigenous populations in the AmericasThe prevalence of human T-lymphotropic virus infection among blood donors in southeast China, 2004-2013.A retrospective analysis of false-positive infectious screening results in blood donorsInfection with human T-lymphotropic virus types-1 and -2 (HTLV-1 and -2): Implications for blood transfusion safety.Racial Patterns of Peripheral T-Cell Lymphoma Incidence and Survival in the United States.Inflammatory manifestations of HTLV-1 and their therapeutic options.Infection with human retroviruses other than HIV-1: HIV-2, HTLV-1, HTLV-2, HTLV-3 and HTLV-4.Testing for HTLV 1 and HTLV 2 among blood donors in Western Saudi Arabia: prevalence and cost considerations.Development of a multisystem surveillance database for transfusion-transmitted infections among blood donors in the United States.Human T-Lymphotropic Virus Type 1 and 2 Seroprevalence among first-time blood donors in Chile, 2011-2013.Seroepidemiology of human T-cell lymphotropic virus among Iranian adult thalassemic patients.HTLV-1-associated myelopathy/tropical spastic paraparesis.Fine-scale geographic clustering pattern of human T-cell leukemia virus type 1 infection among blood donors in Kyushu-Okinawa, Japan.
P2860
Q26772130-6F221747-6599-4F2B-B9BE-F4D6FB214FEBQ26996748-ABB981D3-1D4F-4B7E-9495-B027481FC4F2Q35241181-C63721B2-84AE-4D2D-A8B3-475355628771Q36788008-76C69AEB-D637-44A3-9C43-D13317974A87Q37296863-3A3A34B2-D89A-4144-9810-4B3FB486D20DQ37350788-7171C8EA-3EEF-4D56-8681-4A2F822687E8Q38262169-741186FA-D00A-4FCE-9645-4791D987AD50Q38538043-68F36EAB-4D02-4D8F-A2B1-CC56EF8FAF95Q38705687-2F30DE92-58BD-469C-A1CB-67CF2BD6A447Q39457208-092787B8-CA69-425F-B65E-CF3D8655525FQ40354624-181DAF28-A4D3-401F-BB79-50C59C3D9A58Q42199922-955D6997-376C-4F39-B1BE-FA75F15FED4BQ45096240-99EA975F-1245-4EB3-B5C5-61891EC28719Q55239042-8DD2CE3F-36FD-4AA8-A2BE-8FAF27AA1DE7
P2860
Seroprevalence and demographic determinants of human T-lymphotropic virus type 1 and 2 infections among first-time blood donors--United States, 2000-2009.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 September 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Seroprevalence and demographic ...... ors--United States, 2000-2009.
@en
Seroprevalence and demographic ...... ors--United States, 2000-2009.
@nl
type
label
Seroprevalence and demographic ...... ors--United States, 2000-2009.
@en
Seroprevalence and demographic ...... ors--United States, 2000-2009.
@nl
prefLabel
Seroprevalence and demographic ...... ors--United States, 2000-2009.
@en
Seroprevalence and demographic ...... ors--United States, 2000-2009.
@nl
P2093
P2860
P921
P356
P1476
Seroprevalence and demographic ...... ors--United States, 2000-2009.
@en
P2093
Barbara Hoose
Daniel Hindes
Denise Dubay
Edward L Murphy
Hany Kamel
Marjorie Bravo
Nancy Kiely
Yun Brenda Chang
Zhanna Kaidarova
P2860
P304
P356
10.1093/INFDIS/JIT497
P407
P577
2013-09-24T00:00:00Z